Document is current
Any future updates will be listed below
-
Authors
Lee, Michael Y.
Bedia, Jacob S. http://orcid.org/0000-0003-1599-8865
Bhate, Salil S. http://orcid.org/0000-0002-2057-9182
Barlow, Graham L. http://orcid.org/0000-0001-9335-5414
Phillips, Darci http://orcid.org/0000-0002-0804-3342
Fantl, Wendy J. http://orcid.org/0000-0003-3452-7292
Nolan, Garry P. http://orcid.org/0000-0002-8862-9043
Schürch, Christian M. http://orcid.org/0000-0002-1792-1768
-
Funding
Funding for this research was provided by:
National Institutes of Health
U.S. Department of Defense
Bill and Melinda Gates Foundation
U.S. Food and Drug Administration
Cancer Research Institute
Cancer Research UK
Parker Institute for Cancer Immunotherapy
Kenneth Rainin Foundation
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
BRCA Foundation
- License Information
-
More Information
Article History
Received: 20 April 2021
Accepted: 10 January 2022
First Online: 18 January 2022
Declarations
:
: Not applicable.
: Not applicable.
: M.Y.L. is a co-founder of and has equity in Biodock, Inc. G.P.N. is a co-founder and stockholder of Akoya Biosciences, Inc., and inventor on patent US9909167. C.M.S. is a scientific advisor to, has stock options in, and has received research funding from Enable Medicine, Inc. The other authors declare that no competing financial interests exist.
